US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 3.5000
  • +0.0600+1.74%
Close Jul 11 16:00 ET
  • 3.4500
  • -0.0500-1.43%
Post 19:40 ET
3.29MMarket Cap0.28P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avenue Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-15.40

+84.84%
Analyst Rating

Buy

Jul 2, 2024

Avenue Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Avenue Therapeutics Earnings Reports

  • Avenue Therapeutics | 10-Q: Quarterly report

    May 15 16:26 ET

  • Avenue Therapeutics | 10-K: Annual report

    Mar 18 16:23 ET

  • Avenue Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:15 ET

  • Avenue Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:25 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg